Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Measuring Tim-3 on neutrophils to gauge ankylosing spondylitis activity

Measures Tim-3 on neutrophils in adults with ankylosing spondylitis, a spinal arthritis.

Plain-language title generated from the registry record
Registry title: Expression of Tim-3 on Neutrophils in Ankylosing Spondylitis

Key facts

Where
Asyut, EgyptSee the site

Where in Egypt

  • Assiut UniversityAsyut, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assiut University
Trial code
NCT07383805
Record updated
3 February 2026
Original description
1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers. 2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .Read full original descriptionShow less

Expression of T Cell Immunoglobulin and Mucin-domain Containing Molecule 3 (Tim-3) on Neutrophils as an Indicator to Assess Disease Activity in Ankylosing Spondylitis Patients

1. To investigate the expression of Tim-3 on neutrophils in ankylosing spondylitis patients and its correlation with disease activity and inflammatory markers. 2. Association of Tim-3 with sacroiliac MRI findings and the hip inflammatory MRI scoring system (HIMRISS) .

Adult patients (>18 years) diagnosed as AS according to 2009 ASAS -Classification criteria (8) Exclusion Criteria:-Age below 18 years old. Patients with other autoimmune diseases. infection (cause increase in inflammatory makers) Any patient with ferromagnetic implants or cardiac pacemaker pregnancy Uncontrolled Hypertension renal failure Chronic liver disease Malignancy Diabetes Mellitus.

ClinicalTrials.gov NCT07383805